Literature DB >> 33941620

Autism-Associated Vigilin Depletion Impairs DNA Damage Repair.

Shahid Banday1, Raj K Pandita2,3, Arjamand Mushtaq1, Albino Bacolla4, Ulfat Syed Mir1, Dharmendra Kumar Singh2, Sadaf Jan1, Krishna P Bhat5, Clayton R Hunt2, Ganesh Rao3, Vijay K Charaka2, John A Tainer4,6, Tej K Pandita2,3, Mohammad Altaf1,7.   

Abstract

Vigilin (Vgl1) is essential for heterochromatin formation, chromosome segregation, and mRNA stability and is associated with autism spectrum disorders and cancer: vigilin, for example, can suppress proto-oncogene c-fms expression in breast cancer. Conserved from yeast to humans, vigilin is an RNA-binding protein with 14 tandemly arranged nonidentical hnRNP K-type homology (KH) domains. Here, we report that vigilin depletion increased cell sensitivity to cisplatin- or ionizing radiation (IR)-induced cell death and genomic instability due to defective DNA repair. Vigilin depletion delayed dephosphorylation of IR-induced γ-H2AX and elevated levels of residual 53BP1 and RIF1 foci, while reducing Rad51 and BRCA1 focus formation, DNA end resection, and double-strand break (DSB) repair. We show that vigilin interacts with the DNA damage response (DDR) proteins RAD51 and BRCA1, and vigilin depletion impairs their recruitment to DSB sites. Transient hydroxyurea (HU)-induced replicative stress in vigilin-depleted cells increased replication fork stalling and blocked restart of DNA synthesis. Furthermore, histone acetylation promoted vigilin recruitment to DSBs preferentially in the transcriptionally active genome. These findings uncover a novel vigilin role in DNA damage repair with implications for autism and cancer-related disorders.

Entities:  

Keywords:  DNA repair; Rad51; autism-related disorders; cancer; histone acetylation; homologous recombination; replicative stress; vigilin

Mesh:

Substances:

Year:  2021        PMID: 33941620      PMCID: PMC8224237          DOI: 10.1128/MCB.00082-21

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  85 in total

Review 1.  Genomic instability--an evolving hallmark of cancer.

Authors:  Simona Negrini; Vassilis G Gorgoulis; Thanos D Halazonetis
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

2.  Interplay between human DNA repair proteins at a unique double-strand break in vivo.

Authors:  Amélie Rodrigue; Matthieu Lafrance; Marie-Christine Gauthier; Darin McDonald; Michael Hendzel; Stephen C West; Maria Jasin; Jean-Yves Masson
Journal:  EMBO J       Date:  2006-01-05       Impact factor: 11.598

3.  MOF and histone H4 acetylation at lysine 16 are critical for DNA damage response and double-strand break repair.

Authors:  Girdhar G Sharma; Sairei So; Arun Gupta; Rakesh Kumar; Christelle Cayrou; Nikita Avvakumov; Utpal Bhadra; Raj K Pandita; Matthew H Porteus; David J Chen; Jacques Cote; Tej K Pandita
Journal:  Mol Cell Biol       Date:  2010-05-17       Impact factor: 4.272

Review 4.  Functions and mechanisms of non-histone protein acetylation.

Authors:  Takeo Narita; Brian T Weinert; Chunaram Choudhary
Journal:  Nat Rev Mol Cell Biol       Date:  2019-03       Impact factor: 94.444

Review 5.  Conserved structures and diversity of functions of RNA-binding proteins.

Authors:  C G Burd; G Dreyfuss
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

6.  Vigilin interacts with CCCTC-binding factor (CTCF) and is involved in CTCF-dependent regulation of the imprinted genes Igf2 and H19.

Authors:  Qiuying Liu; Bo Yang; Xiaoyan Xie; Ling Wei; Wenquan Liu; Wenli Yang; Yajun Ge; Qiang Zhu; Junzhe Zhang; Lei Jiang; Xiaoqin Yu; Wenyan Shen; Ran Li; Xuejiao Shi; Bo Li; Yang Qin
Journal:  FEBS J       Date:  2014-05-12       Impact factor: 5.542

7.  Mammalian Rad9 plays a role in telomere stability, S- and G2-phase-specific cell survival, and homologous recombinational repair.

Authors:  Raj K Pandita; Girdhar G Sharma; Andrei Laszlo; Kevin M Hopkins; Scott Davey; Mikhail Chakhparonian; Arun Gupta; Raymund J Wellinger; Junran Zhang; Simon N Powell; Joseph L Roti Roti; Howard B Lieberman; Tej K Pandita
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

8.  On the mechanism of induction of heterochromatin by the RNA-binding protein vigilin.

Authors:  Jing Zhou; Qiaoqiao Wang; Ling-Ling Chen; Gordon G Carmichael
Journal:  RNA       Date:  2008-07-22       Impact factor: 4.942

9.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.

Authors:  Brian J O'Roak; Laura Vives; Santhosh Girirajan; Emre Karakoc; Niklas Krumm; Bradley P Coe; Roie Levy; Arthur Ko; Choli Lee; Joshua D Smith; Emily H Turner; Ian B Stanaway; Benjamin Vernot; Maika Malig; Carl Baker; Beau Reilly; Joshua M Akey; Elhanan Borenstein; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Jay Shendure; Evan E Eichler
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

Review 10.  Chromatin remodeling finds its place in the DNA double-strand break response.

Authors:  Tej K Pandita; Christine Richardson
Journal:  Nucleic Acids Res       Date:  2009-01-12       Impact factor: 16.971

View more
  3 in total

1.  Stress Responses as Master Keys to Epigenomic Changes in Transcriptome and Metabolome for Cancer Etiology and Therapeutics.

Authors:  Atanu Mondal; Apoorva Bhattacharya; Vipin Singh; Shruti Pandita; Albino Bacolla; Raj K Pandita; John A Tainer; Kenneth S Ramos; Tej K Pandita; Chandrima Das
Journal:  Mol Cell Biol       Date:  2021-11-08       Impact factor: 5.069

Review 2.  Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.

Authors:  Zu Ye; Yin Shi; Susan P Lees-Miller; John A Tainer
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 8.786

3.  Exploring the ovine sperm transcriptome by RNAseq techniques. I Effect of seasonal conditions on transcripts abundance.

Authors:  Irene Ureña; Carmen González; Manuel Ramón; Marta Gòdia; Alex Clop; Jorge H Calvo; Mª Jesús Carabaño; Magdalena Serrano
Journal:  PLoS One       Date:  2022-03-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.